Kazia Therapeutics Ltd (ASX:KZA, NASDAQ:KZIA) is ready to showcase data for its paxalisib and EVT801 pipeline molecules to scientists from the American.
/PRNewswire/ Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce the presentation of.